|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.6 SEK | +13.36% |
|
+22.81% | +3.99% |
Coegin Pharma AB reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was SEK 0.075 million compared to SEK 1.37 million a year ago. Net loss was SEK 6.48 million compared to SEK 6.48 million a year ago.
Basic loss per share from continuing operations was SEK 0.007 compared to SEK 0.009 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.99% | 7.45M | |
| +43.36% | 58.06B | |
| -5.31% | 40.53B | |
| +37.52% | 38.99B | |
| +14.75% | 26.7B | |
| -12.56% | 26.56B | |
| -22.45% | 18.98B | |
| +0.04% | 12.17B | |
| +25.12% | 12B | |
| +26.04% | 11.92B |
COEGIN PHARMA AB 
